Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 415
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06851442 | Clinical Trial of Evaluating TQB3912 Tablets Combined With Fulvestrant Injection±TQB3616 Capsules for Locally Advanced or Metastatic Hormone Receptor(HR)-Positive and Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer | ||
| NCT05675202 | Material Balance Study of TQ-B3525 | ||
| NCT05849727 | A Clinical Study of TQH3821 Tablets in the Treatment of Treated Rheumatoid Arthritis | ||
| NCT06156280 | A Clinical Study of TQH2929 in Healthy Adult Subjects | ||
| NCT06566586 | A Clinical Study to Evaluate the Efficacy and Safety of TQB3702 Tablets Combined With Immunochemotherapy for the Treatment of B-cell Lymphoma | ||
| NCT06051565 | Cardiovascular Contrast-enhanced Magnetic Resonance Imaging Using Polysaccharide Superparamagnetic Iron Oxide Injection in Diabetic Patients | ||
| NCT03589950 | Anlotinib Plus Chemotherapy for Patients With Advanced Non-small Cell Lung Cancer | ||
| NCT05987371 | A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease. | ||
| NCT06585059 | Clinical Trial of TQB2928 in Combination With a Third-Generation Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Patients With Advanced Non-Small Cell Lung Cancers | ||
| NCT02469883 | A Study of Sinotecean on Tolerance and Pharmacokinetics | ||
| NCT03714568 | Pharmacokinetic and Tolerance Study of TQ-A3326 in Healthy Participants. | ||
| NCT06438783 | TQB2928 Injection Combined Anlotinib Hydrochloride Capsule in Recurrent/Metastatic Osteosarcoma and Other Solid Tumors | ||
| NCT05292196 | A Phase II Clinical Trial of TQC3721 Suspension for Inhalation | ||
| NCT06139367 | A Clinical Trial of TQB3454 Tablets in Healthy Adult Subjects | ||
| NCT03743129 | Anlotinib After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer（ALTER-L029） | ||
| NCT01874873 | A Phase II Study of Anlotinib in MTC Patients | ||
| NCT02930317 | Evaluate Efficacy and Safety of Recombinant Factor VIII （rFVIII）Treatment of Severe or Moderately Severe Hemophilia A | ||
| NCT04956328 | Study of Obeticholic Acid（OCA） Combination With Ursodeoxycholic Acid (UDCA) in Patients With Primay Biliary Cirrhosis (PBC) | ||
| NCT06434467 | The Efficacy and Safety of Nelarabine Injection in Patients With T-lymphoblastic Leukemia and T-lymphoblastic Lymphoma | ||
| NCT06561607 | A Clinical Trial to Evaluate the Efficacy and Safety of TQB2102 for Injection Versus Investigator-Selected Chemotherapy in HER2 Low-Expressing Recurrent/Metastatic Breast Cancer | ||
| NCT04306887 | A Study of TQ-B3101 in Subjects With Relapsed or Refractory Anaplastic Large Cell Lymphoma (ALCL) | ||
| NCT04234607 | A Study of TQB2450 or Placebo Combined With Anlotinib, Etoposide and Carboplatin Versus Etoposide and Carboplatin in Subjects With Extensive Small Cell Lung Cancer (ETER701) | ||
| NCT03624309 | Anlotinib Plus Docetaxel for the Treatment of EGFR Wild-type Advanced Non-small-cell Lung Cancer | ||
| NCT06487416 | A Trial to Assess the Bioequivalence of Tiotropium Bromide Inhalation Powder in Healthy Adult Participants Under Fasting Conditions | ||
| NCT05121363 | A Clinical Trial to Evaluate TQB2858 Injection Combined With Anlotinib Hydrochloride Capsule in the Treatment of Recurrent or Metastatic Advanced Endometrial Carcinoma | ||
| NCT02449343 | Study of Anlotinib in Patients With Soft Tissue Sarcoma（STS）(ALTER0203) | ||
| NCT04808570 | A Study of TQ-B3525 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | ||
| NCT05344729 | Clinical Trial for Effect of TQB3616 Capsule on Pharmacokinetics in Healthy Adult Subjects | ||
| NCT04009317 | Study of TQ-B3139 Versus Crizotinib in the First Line Treatment of Subjects With Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) | ||
| NCT04213118 | Anlotinib Combined With TACE in Hepatocellular Carcinoma Patients at High Risk of Post Surgery Recurrence | ||
| NCT05576480 | SCRT Sequential Penpulimab in Combination With CAPEOX in the Neoadjuvant Treatment of MSS Locally Advanced Rectal Cancer | ||
| NCT04337879 | A Study of AL2846 Capsule Combined With Standard Chemotherapy Regimen in Subjects With Advanced Colorectal Cancer | ||
| NCT03986073 | Study of TQ-F3083 Capsules in Subjects With Type 2 Diabetes Mellitus | ||
| NCT04273815 | A Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets | ||
| NCT04569838 | A Study to Evaluate the Efficacy and Safety of Bendamustine Hydrochloride Injection | ||
| NCT04029350 | Study of Anlotinib Combined With Osimertinib as Second-line Treatment in Stage IIIb-IV NSCLC With Confirmed EGFRm and T790M | ||
| NCT03099330 | A Phase I Study of TQ-B3139 on Tolerance and Pharmacokinetics | ||
| NCT03790228 | Anlotinib Combined With Pemetrexed And Carboplatin as First-line Treatment in Advanced Nonsquamous NSCLC | ||
| NCT06278493 | A Clinical Study of AL2846 Capsule Combined With Gemzar Injection in the Treatment of Advanced Pancreatic Cancer | ||
| NCT01846650 | A Bioequivalence Study of Capecitabine Tablets | ||
| NCT03850873 | A Phase I Study of TQB3616 on Tolerance and Pharmacokinetics | ||
| NCT03456466 | Study of TQB2303 in Patients With Aggressive CD20 Positive Non-Hodgkin's Lymphoma | ||
| NCT05997342 | A Clinical Study of TQB3912 Tablets in Patients With Advanced Malignant Tumor | ||
| NCT02403544 | Phase I Study of Image-Guided Radiation Concurrent With Double-Agent Chemotherapy for Hepatocellular Carcinoma | ||
| NCT06962267 | A Clinical Study on the First-line Treatment of Metastatic Pancreatic Cancer With TQB2916 Injection Combined With Gemcitabine Hydrochloride for Injection and Paclitaxel for Injection (Albumin-bound Type) | ||
| NCT04853498 | A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3720 Tablets | ||
| NCT05987358 | A Clinical Study of TQB3454 Tablets in the Treatment of Advanced Biliary Carcinoma. | ||
| NCT05834543 | Clinical Trial to Evaluate the Safety and Effectiveness of TQB2618 Injection Combined Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma | ||
| NCT06150014 | A Clinical Study of TQA3605 Tablets Monotherapy or in Combination With Nucleoside (Acid) Analogues in Treatment Naive and Treated Patients With Chronic Hepatitis B | ||
| NCT04842526 | Efficacy and Safety of Anlotinib, Irinotecan and Temozolomide in the Treatment of Refractory or Recurrent Neuroblastoma in Children: an Open, Single Arm, Single Center, Phase II Clinical Study |
